Logo image of TRUE

TRUECAR INC (TRUE) Stock Fundamental Analysis

USA - NASDAQ:TRUE - US89785L1070 - Common Stock

2.02 USD
-0.15 (-6.91%)
Last: 9/25/2025, 5:55:48 PM
2 USD
-0.02 (-0.99%)
After Hours: 9/25/2025, 5:55:48 PM
Fundamental Rating

3

Overall TRUE gets a fundamental rating of 3 out of 10. We evaluated TRUE against 69 industry peers in the Interactive Media & Services industry. No worries on liquidiy or solvency for TRUE as it has an excellent financial health rating, but there are worries on the profitability. TRUE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TRUE has reported negative net income.
TRUE had a negative operating cash flow in the past year.
In the past 5 years TRUE reported 4 times negative net income.
In multiple years TRUE reported negative operating cash flow during the last 5 years.
TRUE Yearly Net Income VS EBIT VS OCF VS FCFTRUE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -21.06%, TRUE is doing worse than 73.91% of the companies in the same industry.
TRUE has a Return On Equity of -27.68%. This is in the lower half of the industry: TRUE underperforms 63.77% of its industry peers.
Industry RankSector Rank
ROA -21.06%
ROE -27.68%
ROIC N/A
ROA(3y)-30.33%
ROA(5y)-16.84%
ROE(3y)-39.17%
ROE(5y)-21.83%
ROIC(3y)N/A
ROIC(5y)N/A
TRUE Yearly ROA, ROE, ROICTRUE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 80.12%, TRUE is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
TRUE's Gross Margin has declined in the last couple of years.
TRUE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.04%
GM growth 5Y-1.56%
TRUE Yearly Profit, Operating, Gross MarginsTRUE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

TRUE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TRUE has been reduced compared to 1 year ago.
TRUE has less shares outstanding than it did 5 years ago.
There is no outstanding debt for TRUE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TRUE Yearly Shares OutstandingTRUE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TRUE Yearly Total Debt VS Total AssetsTRUE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

TRUE has an Altman-Z score of -1.38. This is a bad value and indicates that TRUE is not financially healthy and even has some risk of bankruptcy.
TRUE has a Altman-Z score of -1.38. This is in the lower half of the industry: TRUE underperforms 75.36% of its industry peers.
There is no outstanding debt for TRUE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACCN/A
WACC9.6%
TRUE Yearly LT Debt VS Equity VS FCFTRUE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 4.51 indicates that TRUE has no problem at all paying its short term obligations.
The Current ratio of TRUE (4.51) is better than 82.61% of its industry peers.
A Quick Ratio of 4.51 indicates that TRUE has no problem at all paying its short term obligations.
TRUE has a better Quick ratio (4.51) than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 4.51
TRUE Yearly Current Assets VS Current LiabilitesTRUE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

TRUE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -335.90%.
TRUE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.66%.
Measured over the past years, TRUE shows a very negative growth in Revenue. The Revenue has been decreasing by -12.12% on average per year.
EPS 1Y (TTM)-335.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)11.66%
Revenue growth 3Y-8.83%
Revenue growth 5Y-12.12%
Sales Q2Q%12.45%

3.2 Future

TRUE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.95% yearly.
Based on estimates for the next years, TRUE will show a small growth in Revenue. The Revenue will grow by 7.96% on average per year.
EPS Next Y-119.11%
EPS Next 2Y-25.96%
EPS Next 3Y13.49%
EPS Next 5Y17.95%
Revenue Next Year5.58%
Revenue Next 2Y5.61%
Revenue Next 3Y8.56%
Revenue Next 5Y7.96%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRUE Yearly Revenue VS EstimatesTRUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
TRUE Yearly EPS VS EstimatesTRUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TRUE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TRUE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRUE Price Earnings VS Forward Price EarningsTRUE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRUE Per share dataTRUE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as TRUE's earnings are expected to grow with 13.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.96%
EPS Next 3Y13.49%

More info and screens

0

5. Dividend

5.1 Amount

TRUE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRUECAR INC

NASDAQ:TRUE (9/25/2025, 5:55:48 PM)

After market: 2 -0.02 (-0.99%)

2.02

-0.15 (-6.91%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners74.42%
Inst Owner Change-2.72%
Ins Owners3.08%
Ins Owner Change0.46%
Market Cap178.65M
Analysts75
Price Target2.68 (32.67%)
Short Float %1.19%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.86%
Min EPS beat(2)1.96%
Max EPS beat(2)11.76%
EPS beat(4)3
Avg EPS beat(4)-1.72%
Min EPS beat(4)-22.55%
Max EPS beat(4)11.76%
EPS beat(8)7
Avg EPS beat(8)21.27%
EPS beat(12)9
Avg EPS beat(12)15.4%
EPS beat(16)11
Avg EPS beat(16)2.16%
Revenue beat(2)1
Avg Revenue beat(2)1.28%
Min Revenue beat(2)-0.74%
Max Revenue beat(2)3.31%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-4.2%
Max Revenue beat(4)3.31%
Revenue beat(8)2
Avg Revenue beat(8)-1.75%
Revenue beat(12)2
Avg Revenue beat(12)-3.53%
Revenue beat(16)2
Avg Revenue beat(16)-5.01%
PT rev (1m)3.95%
PT rev (3m)3.95%
EPS NQ rev (1m)20%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.2%
Revenue NQ rev (1m)1.86%
Revenue NQ rev (3m)-0.29%
Revenue NY rev (1m)0.71%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.09
BVpS1.2
TBVpS1.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.06%
ROE -27.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.12%
FCFM N/A
ROA(3y)-30.33%
ROA(5y)-16.84%
ROE(3y)-39.17%
ROE(5y)-21.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.04%
GM growth 5Y-1.56%
F-Score4
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.74%
Cap/Sales 4.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.51
Quick Ratio 4.51
Altman-Z -1.38
F-Score4
WACC9.6%
ROIC/WACCN/A
Cap/Depr(3y)60.34%
Cap/Depr(5y)59.43%
Cap/Sales(3y)6.38%
Cap/Sales(5y)5.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-335.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-119.11%
EPS Next 2Y-25.96%
EPS Next 3Y13.49%
EPS Next 5Y17.95%
Revenue 1Y (TTM)11.66%
Revenue growth 3Y-8.83%
Revenue growth 5Y-12.12%
Sales Q2Q%12.45%
Revenue Next Year5.58%
Revenue Next 2Y5.61%
Revenue Next 3Y8.56%
Revenue Next 5Y7.96%
EBIT growth 1Y4.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.01%
EBIT Next 3Y35.82%
EBIT Next 5Y19.34%
FCF growth 1Y77.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.86%
OCF growth 3Y-18.43%
OCF growth 5Y-17.65%